SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-021903
Filing Date
2020-05-06
Accepted
2020-05-06 16:01:18
Documents
3
Period of Report
2020-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nltx-8k_20200506.htm 8-K 36114
2 EX-99 nltx-ex99_6.htm EX-99 100449
3 GRAPHIC glwlgoxn1qob000001.jpg GRAPHIC 6144
  Complete submission text file 0001564590-20-021903.txt   146519
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 20852515
SIC: 2834 Pharmaceutical Preparations